Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008140 |
---|---|
Receipt number | R000009588 |
Scientific Title | A phase II study of Paclitaxel combined with Bevacizumab in HER2 negative metastatic Breast Cancer |
Date of disclosure of the study information | 2012/06/12 |
Last modified on | 2021/12/19 22:02:44 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/06/11 20:55:30 | ||
2 | Update | 2014/07/24 08:23:48 | Email Email1 |
|
3 | Update | 2021/12/18 14:25:56 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
4 | Update | 2021/12/19 22:02:44 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Organization Organization Address Address Tel |